相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Investigation into the origins of an ancientBRCA1founder mutation identified among Chinese families in Singapore
Tarryn Shaw et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Missense PALB2 germline variant disrupts nuclear localization of PALB2 in a patient with breast cancer
Ming Ren Toh et al.
FAMILIAL CANCER (2020)
Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines
Min-Kyung So et al.
BREAST CANCER (2019)
Variant classification changes over time in BRCA1 and BRCA2
Chloe Mighton et al.
GENETICS IN MEDICINE (2019)
Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European
Mesaki K. Ndugga-Kabuye et al.
FAMILIAL CANCER (2019)
Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance
Ginger J. Tsai et al.
GENETICS IN MEDICINE (2019)
A scientometric review of genome-wide association studies
Melinda C. Mills et al.
COMMUNICATIONS BIOLOGY (2019)
Functional analysis of clinical BARD1 germline variants
Ming Ren Toh et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2019)
Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk
Jennifer L. Caswell-Jin et al.
GENETICS IN MEDICINE (2018)
Observed frequency and challenges of variant reclassification in a hereditary cancer clinic
Sarah Macklin et al.
GENETICS IN MEDICINE (2018)
Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry
Thomas P. Slavin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry
Thomas P. Slavin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing
Jacqueline Mersch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Mutation screening of 10 cancer susceptibility genes in unselected breast cancer patients
Y. Xie et al.
CLINICAL GENETICS (2018)
Impact of subsidies on cancer genetic testing uptake in Singapore
Shao-Tzu Li et al.
JOURNAL OF MEDICAL GENETICS (2017)
Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer
Allison W. Kurian et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory
William Gradishar et al.
ONCOLOGIST (2017)
Characterization of BRCA1 and BRCA2 variants in multi- ethnic Asian cohort from a Malaysian case-control study
Kah Nyin Lai et al.
BMC CANCER (2017)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort
Charite Ricker et al.
CANCER GENETICS (2016)
Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore
Edward S. Y. Wong et al.
NPJ GENOMIC MEDICINE (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes
J. M. Eggington et al.
CLINICAL GENETICS (2014)
Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients
Holly LaDuca et al.
GENETICS IN MEDICINE (2014)
Personalized cancer genetics training for personalized medicine: Improving community-based healthcare through a genetically literate workforce
Kathleen R. Blazer et al.
GENETICS IN MEDICINE (2011)
Genetic testing and cancer risk management recommendations by physicians for at-risk relatives
Sharon E. Plon et al.
GENETICS IN MEDICINE (2011)
Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: Variant reclassification and surgical decisions
Mitzi L. Murray et al.
GENETICS IN MEDICINE (2011)
Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes
Suzanne C. O'Neill et al.
PSYCHO-ONCOLOGY (2009)
Molecular Origins of Cancer: Inherited Susceptibility to Common Cancers
William D. Foulkes
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Uptake rates for breast cancer genetic testing: A systematic review
Mary E. Ropka et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Genetic testing in an ethnically diverse cohort of high-risk women -: A comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry
R Nanda et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Prevalence of BRCA mutations and founder effect in high-risk Hispanic families
JN Weitzel et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Early adoption of BRCA1/2 testing:: Who and why
K Armstrong et al.
GENETICS IN MEDICINE (2003)
分享论文
